Search

You searched for "vitrectomy"

263 results found

End of an era: completing training. Tips for survival, fellowship applications and how to CCT

1 February 2019 | | EYE - General
Tafadzwa Young-Zvandasara shares the things he wishes he had paid more attention to when approaching the end of training. It is the end of an era, you are now ready to move on. Training has been filled with a structured...

Surgical management of IIIcnp

1 December 2018 | | EYE - Paediatrics, EYE - Strabismus
This was a retrospective review of a cohort of patients with complete third nerve palsy (IIIcnp) managed by a surgical technique of full tendon transposition (FTT) of the lateral rectus (LR) to the medial rectus (MR) augmented with posterior fixation...

Nishida procedure for VIcnp

1 August 2019 | | EYE - Paediatrics, EYE - Strabismus
This study reports results in treatment of complete sixth nerve palsy (VIcnp) by modified Hummelscheim (Nishida’s) procedure; vertical muscle halves after splitting were secured with anchoring sutures to the sclera with anchoring of only the temporal muscle margins to the...

The Gambia-Swansea VISION 2020 LINK: building eye care services and international friendships

1 June 2014 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
History The VISION 2020 LINK between the Sheikh Zayed Regional Eye Care Centre (SZRECC), Banjul, The Gambia and the Ophthalmology Department, Singleton Hospital, Swansea started in 2008 under the guidance of the VISION 2020 LINKS Programme at the International Centre...

The management of retinal vein occlusions: a summary

1 February 2015 | | EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...

Considerations in the management of retinal disorders

1 October 2017 | | EYE - Vitreo-Retinal
Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

1 December 2016 | | EYE - Vitreo-Retinal
Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...

NICE drugs: an update on what’s good to go

1 June 2014 | | EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...

Advances and developments in medical retina

1 February 2019 | | EYE - Vitreo-Retinal, EYE - General
The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...

Newer generation IOL platforms designed for high-quality visual performance after cataract surgery

1 April 2019 | | EYE - Cataract, EYE - Refractive, EYE - General
Expanding intraocular lens (IOL) capabilities provide broadening options, ranging from next-generation monofocal IOLs for basic cataract surgery, to specialised premium IOLs for lens-based presbyopia correction and astigmatism correction at the time of cataract surgery. Rod McNeil considers several newer alternative...

Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting

2 December 2019 | | EYE - Vitreo-Retinal, EYE - General
The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

5 February 2020 | | EYE - Vitreo-Retinal, EYE - General
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...